NASDAQ:HKPD | News | Cellyan Biotechnology Co., Ltd

HKPD News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-07-16Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2026-03-27Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2026-03-18Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2026-01-16Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-12-31Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-12-17Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-11-24Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-11-12Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-10-07Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-09-11Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-03-28Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.
2025-01-17Foreign issuer reportSEC filingCellyan Biotechnology Co., Ltd filed Form 6-KCellyan Biotechnology Co., Ltd filed Form 6-K.